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Abstract
The group randomized trial (GRT) is a common study design to assess the effect of an intervention program aimed at health
promotion or disease prevention. In GRTs, groups rather than individuals are randomized into intervention or control arms.
Then, responses are measured on individuals within those groups. A number of analytical problems beset GRT designs. The
major problem emerges from the likely positive intraclass correlation among observations of individuals within a group. This
paper provides an overview of the analytical method for GRT data and applies this method to a randomized cancer
prevention trial, where multiple binary primary endpoints were obtained. We develop an index of extra variability to
investigate group-specific effects on response. The purpose of the index is to understand the influence of individual groups
on evaluating the intervention effect, especially, when a GRT study involves a small number of groups. The multiple
endpoints from the GRT design are analyzed using a generalized linear mixed model and the stepdown Bonferroni method
of Holm.
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Introduction
This paper addresses data analysis issues related to group
randomized trials (GRTs) with multiple endpoints and a small
number of groups. In GRT studies, groups serve as the primary
sampling unit in the selection process; groups are randomized into
two or more arms, and then responses are measured on individuals
within those groups. Typical examples of groups include clinics,
schools, work sites, churches, or communities.
GRT is becoming a standard study design to assess the effect of
an intervention program for health promotion or disease
prevention, especially when the intervention is delivered more
efficiently to groups than directly to individuals [1].
Consider the data from a study of the cancer Screening Office
System (cancer SOS) [2], which motivated this research and are
analyzed herein. In the study, eight primary care clinics were
randomly selected and assigned to either the intervention or
control arms. Then, patients from the clinics were randomly
selected and a chart review was conducted to assess whether or not
they took a given cancer screening test sometime during the
preceding year. This assessment was made at three time points:
baseline, 12 and 24 months post intervention.
In contrast to standard randomized clinical trials in which
individuals are the sampling units for randomization, GRT designs
have additional analytical problems. The major problem is due to
the expected positive intraclass correlation (ICC) among observa-
tions from individuals in the same group. In addition, the number
of groups involved in GRT studies is generally quite small, and
thus problems arise in obtaining an accurate estimate of the ICC.
In spite of its difficulties, however, the GRT approach may
sometimes be the only feasible approach; and if the characteristics
of the GRT design are not properly accounted for in the analysis,
the statistical significance of the intervention effect is typically
overestimated, resulting in misleading public health information.
Data analysis issues of GRTs have been intensively discussed by
health science researchers [1,3–5] and a number of studies that
used inappropriate statistical analysis methods have been identified
[4,6–10]. Recently, a statement from the Consolidated Standard
of Reporting Trials (CONSORT) group emphasized the major
analytical problems associated with GRTs, and recommended
guidelines for reporting about them [6]. Many journals now
require that the reports conform to the CONSORT guidelines.
We believe that further education regarding the proper analysis of
GRT-type data is necessary.
Analytically, it is most straightforward for a clinical trial to have
a single primary question. For some research, however, multiple
primary endpoints are important and relevant scientifically,
medically, or for public health purposes, as it is often difficult to
fully assess the efficacy of a new intervention using a single
endpoint. Moreover, these studies are often expensive in both cost
and effort, so researchers would like to get answers to many
questions with a given study, if feasible. For example, the cancer
SOS intervention study was designed to increase the use of three
major cancer screening tests. For each patient, evaluations of the
intervention were made for each test. Thus, patients were
measured for the three tests as co-primary endpoints to better
characterize the efficacy of the intervention, leading to an outcome
variable that is a vector of three responses.
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a major research area in statistics, and several statistical computing
packages (e.g., SAS, S-PLUS) have software procedures for
analyzing such data. In spite of recent progress though,
multivariate analysis is still not a standard approach for analysts
who do not routinely use mixed models. Although many papers
have explained the theoretical basis for multivariate analysis, few
practical introductions to GRTs with multiple endpoints have
been written, especially in the context of public health medicine.
Generalized linear mixed models (GLMMs) [11,12] provide a
suitable framework for handling a GRT design. In this paper, we
show how to use GLMMs to analyze GRT data arising from a
randomized cancer prevention trial. We can incorporate covar-
iates into GRT analysis by formulating the problem in the context
of GLMMs.
When a study involves multiple endpoints addressing equally
important objectives of the proposed intervention, the potential for
drawing false positive conclusions exists unless an appropriate
adjustment for multiplicity is used to control the overall statistical
error rate. Several possible approaches exist, with appropriateness
depending upon the study design. In this study, the multiple
endpoints will be adjusted using the stepdown Bonferroni method,
which we will refer to as Holm’s method [13].
Use of a small number of groups in a GRT raises additional
concerns regarding the statistical analysis of the intervention effect.
Also, statistical power of a GRT generally depends more on the
number of groups randomized than on the average number of
individuals within a group [3]. Unfortunately, due to logistics and
cost, a GRT commonly involves a small number of groups. From
an analytical perspective, a GRT involving few groups intensifies
the effect that any single group’s behavior has on the overall
intervention effect. Thus, it is critical for investigators to
understand each group’s influence, which poses greater problems
if one group is markedly different than the others. In this study, we
will develop an index of extra variability to investigate group-
specific effects on response. The index is designed to gauge the
heterogeneity of response among the individual groups and
provide insights into their influence on the GRT study.
This article provides practical advice and methodology for
analyzing GRTs data, especially with multiple endpoints and a
small number of groups. The overarching goal of this work is to
disseminate statistical knowledge for public health benefit. This
paper can be viewed as a tutorial for researchers who have little
theoretical background or practical experience analyzing GRTs
data, especially with multiple endpoints and a small number of
groups. Mathematical details are avoided unless needed to
illustrate important concepts.
Methods
Group randomized trials and statistical issues
A GRT is a randomized clinical trial to investigate an
intervention. Unlike standard randomized clinical trials, however,
the intervention is delivered to individuals through ‘‘groups’’,
which are assigned to either intervention or control arms.
Responses are measured on individuals within those groups nested
in the arms. Consequently, the responses for individuals within the
same group are expected to be positively correlated. This
correlation is called the intraclass correlation coefficient (ICC),
and is denoted by r.
Although r in most GRTs is usually rather small, this
dependence can substantially influence the design and analysis of
the GRT. If the ICC is ignored, the point estimate of the
intervention effect is not affected. However, statistical inferences
through the standard errors, p-values, and confidence intervals can
be substantially affected.
To explain the concept of the ICC simply, suppose we conduct
a nested cross-sectional GRT design. Let the two arms have the
same number of groups, g, and all groups have the same number
of members, m, following Murray’s notation [1]. In addition,
suppose we measure the endpoint at least two times post
intervention. The total variance of the response s2
y is defined
as s2
y~s2
ga ðÞ zs2
gt a ðÞ zs2
e, where s2
ga ðÞ ,s2
gt a ðÞ , and s2
e are the
between-group, group-by-time interaction, and within-group
variances, respectively. Here, ga ðÞand gt a ðÞrepresent group
and interaction between group and time are nested within arm.
Then, the ICC is defined as
r~
s2
gt a ðÞ
s2
y
~
s2
gt a ðÞ
s2
ga ðÞ zs2
gt a ðÞ zs2
e
: ð1Þ
Note that the ICC varies depending upon the endpoint, the
design, and the analyses. For example, with a nested cohort study
in which the endpoints are repeatedly observed over time from the
same subject, the ICC above will include the within-subject
variance over time.
As seen in equation (1), ICC reflects the proportion of the total
variance explained by the variance of the group-by-time
interaction. The variance of the group mean in a GRT is then,
s2
y
mg
1z m{1 ðÞ r ½  :
Due to the GRT design, the variance includes a multiplicative
factor 1z m{1 ðÞ r ½  , called the variance inflation factor (VIF) [3].
Note that VIF=1 if r~0.I fr is greater than 0, ignoring the VIF
results in underestimating the standard error of the intervention
effect, and hence overestimating the statistical significance of the
intervention effect.
As equation (1) shows, estimation of the ICC requires estimates
of the between-group variance and the group-by-time interaction
variance, with the number of groups as degrees-of-freedom.
Primarily for logistical reasons, GRTs commonly have few groups
(e.g., the four clinics per arm used in the cancer SOS study),
resulting in a small number of degrees-of-freedom (df). This small
df will be used to estimate the standard error for the intervention
effect, and will yield an inflated Type I error. Further, this will
reduce the statistical power of the test. Consequently, both the
design stage and the analysis stage should account for the GRTs’
characteristics.
Analysis of GRTs using GLMM
In this section, we briefly review the generalized linear mixed
model (GLMM) to analyze GRTs. Let’s assume that a vector of
binary response data Y follows a Bernoulli distribution with
unknown parameter m. The response probability, m, needs a link
function so that all possible values of a set of linear predictors map
into the interval between 0 and 1. This is accomplished by using
the log of the odds of m, called the logit link function, written by
logit m ðÞ ~log
m
1{m
  
~XbzZc, ð2Þ
where X is a matrix of observed explanatory variables and Z is a
GRT with Small # of Groups
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fixed effects that need to be estimated, while the vector c of
random effects is not estimable, and is assumed to be normally
distributed with mean 0 and a variance matrix. The variance of
the binary data is defined as,
n Yjc ðÞ ~m 1{m ðÞ : ð3Þ
We analyze the cancer SOS study by testing the intervention
effect for the multiple endpoints in a global fashion. Specifically,
for each of the three screening tests, let Yijk l ðÞ be the binary
response (yes/no) and mijk l ðÞ~Pr Yijk(l)~1
  
be the probability of
taking a screening test for the ith member nested within the k th
clinic and the l th arm and observed at the j th time. The odds
ratio for the effect of intervention can be obtained using a logistic
regression model based on equation (2), and it is given by
logit mijk l ðÞjc
  
~b0zb1Alzb2Tjzb3TAjl ðÞzc1Gkl ðÞ zc2TGjk l ðÞð4Þ
where i~1,   ,m patients; j~0,   ,t times; k~1,   ,c groups;
and l~0,1 arms. Time is modeled as a continuous variable. In the
model, Al is the intervention indicator (1 for intervention, 0 for the
control) that estimates the difference between the intercepts, Tj is
the j th time point, and the coefficient represents an average slope
for the control arm, and TAjl ðÞ is the time-by-intervention
interaction that is the main test of interest as it tests for the
average departure from the slope due to the intervention arm.
In order to account for the expected ICC, group-related factors
were included in the analysis as random effects: the random effect
of the k th group nested within arm l, denoted Gkl ðÞ, as a group-
specific intercept and the random effect of the combination of the
j th time and the k th group nested within arm l, denoted TGjk l ðÞ,
as a group-specific slope. TGjk l ðÞ accounts for the possibility that
the random effect Gkl ðÞmay not have an identical distribution at
each time point. These random effects allow for correlation among
members within a group and for correlation among members
within a group | time combination. We assume that the simple
diagonal covariance matrix models a different variance compo-
nent for each random effect, although other covariance matrices
are possible. The estimated odds ratios for the fixed effects are
then given by exp ^ b b
  
. More precisely, the intervention effect is
tested by considering the statistical significance of the interaction
term, ^ b b3. For the final analysis, we added fixed effects for the
baseline covariates, age (as a continuous variable) and race (a
categorical variable, as shown in Table 1), to the above model to
adjust for possible confounding factors.
When a GRT involves a small number of groups, a few
statistical methods are available to adjust the degrees-of-freedom
in mixed models. For example, Kenward and Roger [15]
proposed a general purpose method based on restricted maximum
likelihood. Their method uses an adjusted F-statistic that reduces
the small sample bias. Its distribution is approximated by the F-
distribution with an approximate denominator degrees-of-free-
dom. This method is easily implemented in some commercial
statistical packages including SAS.
Once the model (4) is fitted, the ICC and the VIF can be
estimated based on the equation (1), with the estimated variances
for the within group, between groups, and a between group-by-
time interaction.
Several possible approaches exist to adjust for multiplicity due
to multiple endpoints, and the appropriateness depends upon the
study design. The adjustment approach could be very conservative
(e.g., Bonferroni method) or less conservative (e.g., Hochberg or
Hommel method). We prefer Holm’s method [13], also known as
the stepdown Bonferroni method (a modification from the
Bonferroni procedure), as it controls the familywise error rate
(FWE) under very general conditions. More powerful methods rely
on additional assumptions, and these methods do not always
control the FWE. Holm’s method is now being widely used and
has been cited over 3,000 times to date (www.isiknowledge.com).
We refer readers to Brown and Russell [16] for detailed
comparisons of various multiple testing procedures. We fit a
GLMM for each endpoint and obtain a p-value corresponding to
b3 of TAjl ðÞfrom equation (4). These marginal p-values are then
adjusted for multiplicity, using Holm’s method (implemented in
several statistical packages, including SAS).
Group and time-specific influences
While VIF provides an interpretation of the overall variance
inflation due to a GRT design, it is critical to understand the
influence of individual groups on evaluating the intervention
effect, especially, when the number of groups is small.
Let us define the change on each endpoint within a particular
interval as,
Table 1. Baseline characteristics at individual level by arm (4
groups per arm).
Control Arm Intervention Arm
Characteristics n=467 % n=468 % p-value
Age (years) 0.270
Under 50 5 1.1 7 1.5
50–59 235 50.3 258 55.1
60z 227 48.6 203 43.4
Race-ethnicity 0.014
White 222 47.5 200 44.0
Black 114 24.4 157 33.6
Hispanic 120 25.7 98 20.9
Other 11 3.2 7 1.5
Marital status 0.005
Married 106 22.7 145 31.0
Non-married 361 77.3 323 69.0
Primary language 0.263
English 361 77.3 376 80.3
Non-English 106 22.7 92 19.7
Health insurance 0.506
County Health Plan 287 61.5 277 59.2
Medicaid 65 13.9 79 16.9
Medicare 88 18.8 80 17.1
Other 27 5.8 32 6.8
Smoking status 0.706
Smoker 114 24.4 120 25.6
Non-smoker 353 75.6 348 74.4
Health maintenance
visit in past yr 0.049
Yes 268 57.6 239 51.1
No 197 42.3 229 48.9
doi:10.1371/journal.pone.0007265.t001
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where pkjz is the estimated probability of a success (e.g., taking a
screening test) at time jz1, where j~0,   ,t{1 for the kth group
with k~1,   ,c. For notational simplicity, we skip the index l for
an arm under this subsection. For a specific time interval, the
mean of dkj,
{
dj~
Pc
k~1dkj
 
c, and the standard deviation
STD dkj
  
, quantifying the amount of variability about dkj, are
computed.
If we assume that the responses at two time points are
independent, the nominal variance of the average change
{
dj is
based on the binomial distribution. We denote the standard
deviation of this binomial variance by STD. It is obtained as
STD~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
  p pjz 1{  p pjz
  
{ mjz
z
  p pj 1{  p pj
  
{ mj
v u u t
, ð5Þ
where   p pj is the estimated sample mean of the proportions
computed over all groups in each arm, and { mj is the average
number of individuals within arm at time j. Similarly,   p pjz and
{ mjz represent the analogous values for time jz1. Using STD, the
associated 1{a ðÞ 100% confidence interval for
{
dj can be
computed.
As an index of extra variability (IEVkj), STD dkj
  
is compared
to the variability based on the binomial distribution, using the
ratio;
IEVkj~STD dkj
    
STD:
The IEV index describes how spread out the individual group’s
responses are from the mean, within an arm for a particular
period. IEVkj values close to 1 can be interpreted as an indication
of strong similarity in response across the groups.
Results
Cancer SOS intervention
Roetzheim and others [2] developed a low-cost office-systems
intervention called cancer Screening Office Systems (cancer SOS),
for primary care clinics serving disadvantaged populations.
Disadvantaged populations were defined as patients: 1) belonging
to racial or ethnic minorities, 2) of low socioeconomic status, 3)
uninsured, or 4) insured by Medicaid. The scientific question for
this study was whether or not the intervention prompts patients to
take the cancer screening tests described in the next paragraph. In
previous reports [2,14], both men and women were included in
the analyses. The present study focuses only on women.
The intervention was implemented in a county-funded health
insurance plan in Hillsborough County, FL from 2002 to 2004.
Eight clinics were randomly selected, and each was randomly
assigned to either the intervention or control arms.
The intervention included a cancer screening checklist com-
pleted by patients which indicated whether or not they were due
for screening. The intervention targeted three cancer screening
tests: Papanicolaou (Pap) smears, mammograms, and fecal occult
blood tests (FOBT). It is generally recommended that each of these
tests be performed annually for women who are age 50 or older.
One hundred fifty patient’s charts from the clinics were randomly
selected and abstracted to obtain the demographic and clinical
variables at baseline, and outcome variables at baseline, 12, and 24
months after the intervention. By chance, a few patients were
selected more than once. However, as the study was not intended
to follow individuals over time, this design is called a nested cross-
sectional study rather than a cohort study.
Table 1 provides descriptive statistics of the cancer SOS study
sample at the individual level. The table includes p-values from
Fisher’s exact tests comparing control and intervention arms.
Patients attending intervention clinics were more likely to be
African American, married, and have fewer health care visits.
However, there was no significant difference in age, language,
health insurance, or smoking status at baseline.
Application
This section illustrates applications of GLMMs to a GRT study
where the scientific question is whether or not the cancer SOS
intervention convinces patients to take cancer screening tests or
not. Men were excluded from the analysis in this paper, as two of
the three target screening tests applied to women only. Also, the
following exclusion criteria for the women were applied: personal
history of breast cancer for the analysis of mammography,
personal history of cervical cancer or hysterectomy for the analysis
of Pap smear screening, and personal history of colon cancer, or
colonoscopy of double-contrast barium enema in the previous 10
years for the analysis of FOBT.
In each of eight clinics, patients’ usage of the three screening
tests (Pap smear, mammography, and FOBT) was assessed at three
time points (baseline, year 1, and year 2). The responses were
binary (1 if the patient took the test and 0 otherwise). On average,
150 patients per clinic were measured at each time point, with four
clinics assigned to each of two arms (intervention or control).
The distribution of each cancer screening test (numbers and
percentages) at each time period is summarized by arm in Table 2.
The number of eligible women for the Pap smear test was lower
than for the other tests due to a substantial number of
hysterectomies. As an initial informal analysis, it is useful to
examine the screening rates by time. For all tests, the difference
between the two arms was lower at the 24-month compared to the
12-month follow-up. For FOBT, the two arms showed a
considerable difference at baseline (24 vs. 36% for controls and
interventions, respectively), which was maintained over time.
Figure 1 depicts the data for the three screening tests plotted
against time for the 8 clinics. The screening rate trajectories vary
among clinics (solid and dot lines represent intervention and
control groups, respectively). For the intervention arm, the
screening rates increased slightly at year 1 for all three tests, but
had declined by year 2. By contrast, the 1-year screening rate
declined for all tests in the control arm. Individual clinic trends
were fairly similar for mammography and Pap smears, but
strikingly different for FOBT. For the most part, the screening
rates for interventions were higher than those for controls.
The results of the analysis are shown in Table 3. Age and race
(for mammography), and race (for Pap smear) were not significant
and were removed from the final model. None of the screening
tests showed statistical significance at a~0:05 for the intervention
effect (Intervention | Time). Notably, this result differs from the
original analysis [2,14], which inappropriately ignored the GRT
design: those studies reported that the intervention was significant
for Pap smear and FOBT screening tests after one year and two
years, respectively.
Table 4 shows the estimated covariances of the random effects
from the above model as well as the estimated ICC and VIF
values. Even though the ICCs might appear to be modest in size,
the VIFs are substantial. This indicates that the variances of the
intervention effects range from 1.3 to 19.9 times larger than they
GRT with Small # of Groups
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providing a major explanation for the differences in findings from
the original analyses.
The huge differences of VIF across screening tests are more
clearly explained in Figure 2, which depicts the change of
screening rates (%) between two time points by clinic and arm for
each screening test. The symbol of star and the brackets represent
the mean change across clinics and the 90% confidence intervals
(CIs) based on equation (5). Overall, for the Pap smear test, the
changes for the individual clinics (denoted by circle symbols) were
near the mean, and the index of extra variability (IEV) relatively
close to 1. By contrast, the IEV values were much higher for the
FOBT test, except for the 1–2 year change for the control arm.
Specifically, for the intervention arm with the period of 0 to 1 year
(IEV=5.6), two of the four clinics showed marked distances from
the group mean at 234% and 51%. The IEV values for
mammography were usually somewhat higher than they were
for the Pap smear test, in spite of the fact that the VIF for the
mammography test was much lower (1.3. vs. 5.7). This contrast
can be explained by the relative lack of consistency in when the
shifts occurred for Pap smears; the rate was fairly stable from
baseline to one year, but decreased about 15% in the second year
for the intervention groups, whereas the most of the decline among
the control groups was in the first year. The FOBT, likewise,
shows large shifts whose pattern differs by treatment arm.
Discussion
GRT designs are becoming increasingly important in public
health interventions, as it is often easier to randomize at the group
level. Investigators are often surprised by the degree to which
information is attenuated due to intraclass correlation, even
though ICC levels are often quite low in practice. Thus, GRT
designs are usually improved by having as many groups as are
logistically possible. We have developed an index of extra
variability (IEV) with a corresponding graphical presentation for
understanding in greater detail how the effects from individual
groups influence the overall findings. We believe that the IEV
concept will assist researchers in the planning future GRT studies.
The results of the cancer SOS GRT study were disappointing.
Further, the primary investigator of the study, a non-statistician,
was understandably confused at the discrepancy in findings based
Table 2. Distribution of screening (# subjects who took screening test/total subjects) by clinic nested within arm and time
combination in the cancer SOS study.
Control Arm Intervention Arm
Test Clinic Baseline 12 mths 24 mths Clinic Baseline 12 mths 24 mths
Pap Smear
2 31/54 43/68 40/85 5 48/69 50/70 56/79
7 43/65 23/54 25/66 6 35/51 51/70 43/68
8 27/65 22/78 28/72 9 37/70 35/79 12/78
10 47/73 46/77 46/83 11 31/54 40/63 28/69
Total 148/257 134/277 139/306 151/244 176/282 139/294
Rate (%) 57.6 48.4 45.4 61.9 62.4 47.3
Difference
from Control Arm (%) 4.3 14.0 1.9
Mammography
2 64/89 87/107 80/116 5 95/114 108/127 82/113
7 105/124 85/116 79/111 6 88/116 79/115 91/122
8 67/115 55/111 59/118 9 57/107 82/119 54/119
10 101/116 95/120 83/117 11 85/118 95/119 92/120
Total 337/444 322/454 301/462 325/455 364/480 319/474
Rate (%) 75.9 70.9 65.1 71.4 75.8 67.3
Difference
from Control Arm (%) 24.5 4.9 2.2
FOBT
2 2/98 11/120 5/118 5 52/118 54/127 44/119
7 36/126 15/119 19/112 6 6/119 67/119 41/126
8 42/117 4/116 9/122 9 40/108 4/118 17/122
10 30/121 29/125 26/117 11 67/118 68/122 37/122
Total 110/462 59/480 59/469 165/463 193/486 139/489
Rate (%) 23.8 12.3 12.6 35.6 39.7 28.4
Difference
from Control Arm (%) 11.8 27.4 15.8
Time unit is in months (mths).
doi:10.1371/journal.pone.0007265.t002
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doi:10.1371/journal.pone.0007265.g001
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generalized estimating equations (GEE) [17] approach for each
individual endpoint [2,14], found that the intervention increased
all three screening tests at one year follow-up, and had a persistent
effect on the mammography at two year follow-up.
While the GEE method allows for correlation among patients
within a group, it is inappropriate for GRT study designs when the
number of clinics is small, with less than 20 groups per arm, as
noted by Murray et al. [5] and Bellamy et al. [18]. It is known that
the GEE approach generally yields biased estimates of the
variance of fixed effects when the number of groups/clusters is
small [19,20]. Recently, standard software packages are beginning
to correct for the bias issues for GEE with small samples. In
addition, while commonly ignored, the univariate approach for
each individual endpoint requires an adjustment for multiplicity.
While analyzing the cancer SOS study, we faced a few
additional analytical issues that should be discussed. As the
endpoints were measured at three times, some patients were seen
at multiple timepoints by chance. Among the patients surveyed at
baseline, 22% were seen at year 1, and 8% were selected at all
three timepoints. Ideally, the expected intra-patient correlation,
which exists as a consequence of repeated measurements across
time, should be adjusted for when performing statistical inference.
However, in this study we did not consider this additional source
of correlation. The effect of the possible correlation across time is
unknown and needs further investigation. Also, each patient had
three endpoints, resulting in another source of intra-patient
correlation. As the univariate approach ignores the stochastic
dependence among the individual endpoints, it may yield
conservative results. To account for this type of intra-correlation,
one may use a multivariate approach; all three endpoints per
subject unit are simultaneously analyzed by adding a random
effect for individuals. By accounting for the correlation among
endpoints, improved power to detect the overall intervention effect
is expected. In addition, this multivariate approach needs no
multiplicity adjustment, since only one test is being carried out.
However, it should be noted that if the endpoints describe
unrelated aspects of the individual response, or if there is
considerable discrepancy across endpoints, this multivariate
approach is not a reasonable analytical strategy. In this case,
individual tests that are suitably adjusted, as we have done here,
should be used. The cancer SOS showed striking differences in
Table 3. Summary results of the univariate GLMM analyses for the cancer SOS study.
Test Estimate Standard Error Adjusted
Fixed Effect ^ b b S.E. ^ b b DF p-value p-value
Pap Smear
Intercept 2.937 0.569 303.3 0.0
Intervention 0.385 0.308 6.7 0.25
Time 20.022 0.014 6.1 0.17
Intervention|Time 20.006 0.020 6.4 0.78 1.0
Age 20.041 0.009 1654 0.0
Race:Hispanic 0.288 0.114 1654 0.012
Mammography
Intercept 1.201 0.532 6.9 0.092
Intervention 20.144 0.425 6.9 0.71
Time 20.279 0.082 6.2 0.015
Intervention|Time 0.180 0.115 6.0 0.17 0.51
FOBT
Intercept 22.282 0.632 30.5 0.011
Intervention 0.914 0.583 5.6 0.17
Time 20.441 0.299 6.3 0.19
Intervention|Time 0.221 0.416 5.9 0.61 1.0
Age 20.041 0.009 1654 0.0
doi:10.1371/journal.pone.0007265.t003
Table 4. Estimates of covariance-parameters and intra-class coefficient (ICC) & variance inflation factor (VIF) from the univariate
GLMMs.
Test ^ s s2
ga ðÞ ^ s s2
gt a ðÞ ^ s s2
e ICC VIF
Pap Smear 0.139 0.085 1.00 0.069 5.7
Mammography 0.321 0.004 1.00 0.003 1.3
FOBT 0.632 0.312 1.01 0.160 19.9
doi:10.1371/journal.pone.0007265.t004
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the three endpoints provides no reasonable interpretation.
What appears to have happened with the SOS GRT is that the
intervention groups were either stable or had increases in the first year,
while the control groups declined. However, these modest gains were
short-lived, and resulted in large year 2 drops for the intervention
groups. The GRT was not designed to assess this kind of change, or
cope with this degree of heterogeneity, given the small number of
groups. As VIF, IEV, and the graphical presentation in Figure 2 all
provide different, albeit related, information for GRTs, we believe that
they all have a useful role in their analysis. Selecting an appropriate
number of groups and the number of subjects sampled per group in
GRTs depends on several factors: the endpoint variable type, the
method of the analysis, the expected effect size of intervention, and the
estimated intra-cluster correlation c o e f f i c i e n t .T h es a m p l es i z ei s s u eo f
GRTs is another topic that requires separate discussion; we refer to
Donner and Klar [3], and Murray [1] for details.
Our hope is that this paper will contribute to the responsible
analysis of GRTs, thereby helping with the scientific accuracy of
research findings. Multivariate analysis for multiple endpoints in
GRTs is obviously one area that we need to continue further
investigation. Further research on small group issues also is
warranted at both the design and analysis stages.
The SAS code used for this article is available at the first
author’s web: http://personal.health.usf.edu/jlee2/software. Note
that it also includes a Newton-Raphson optimization option to
deal with convergence problems, which we otherwise frequently
ran into for moderately complex mixed models.
Figure 2. Percent change (%) between two time points by each clinic and arm for each screening test, with index of extra variability
(IEV): Arm I0-1,I1-2, C0-1, C1-2: Intervention (I) and Control (C) between baseline and year 1 (0–1) and between year 1 and 2 (1–2). ?:
Mean of difference between two time points across clinics. 0: Individual clinics’ difference in screening proportion between two time points. jj :9 0%
CI based on binomial distribution.
doi:10.1371/journal.pone.0007265.g002
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